Keith Michael Gottesdiener

Insider Reports History

Entity
Individual
Location
900 Fifth Avenue, #8 C, New York, NY
Signature
/s/ Karen Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Michael Gottesdiener:

Insider Reports Filed by Keith Michael Gottesdiener

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. Feb 28, 2025 1 $0 4 Mar 4, 2025 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Dec 5, 2024 1 $0 4 Dec 9, 2024 Officer, Director
PRME Prime Medicine, Inc. Oct 8, 2024 2 $0 4 Oct 10, 2024 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Feb 25, 2024 1 $0 4 Feb 27, 2024 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Nov 11, 2023 2 $0 4 Nov 14, 2023 Officer, Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 10 -$624K 4 Nov 13, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
PRME Prime Medicine, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 President and Chief Executive Officer, Director
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 President and Chief Executive Officer. Exhibit 24 - Power of Attorney, Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director